Ontology highlight
ABSTRACT:
SUBMITTER: Gottlieb A
PROVIDER: S-EPMC6597927 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
Gottlieb Aline A Best Jan J Canbay Ali A
Visceral medicine 20190208 1
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related death worldwide. Upon ineligibility for resection, liver transplantation, or locoregional therapies, sorafenib has been the only systemic treatment option of advanced HCC for more than a decade. Immunotherapy is an evolving HCC treatment option that has shown promise in treatment efficacy at an acceptable safety profile during several preceding phase I/II trials. Numerous clinical trials of immune checkpoint inhib ...[more]